Skip to content
Screener

Odyssey Therapeutics ODTX Free cash flow margin

Free cash flow margin at other companies

Semtech logo
SemtechSMTC
15.9%+7.7pp
Nucor logo
NucorNUE
5.6%-11.5pp
Northern Trust logo
Northern TrustNTRS
65.1%-24.5pp
Dycom Industries logo
Dycom IndustriesDY
7%+6.1pp
Nordson logo
NordsonNDSN
24.6%+7.6pp
Berkshire Hathaway logo
Berkshire HathawayBRK.A
6.4%—

Other financials

Income statement

See full
Revenue--100%
Operating income-$55.5M-32.3%
Net income-$52.8M-28.0%
EPS (diluted)-$1.74+94.1%

Balance sheet

See full
Cash & equivalents$82.0M-49.7%
Total debt$24.8M+8,175%
Total equity$421.2M+197%
Total assets$483.9M—

Cash flow

See full
Operating cash flow-$34.5M-0.7%
CapEx$186.0K+541%
Free cash flow-$34.7M-1.2%

Valuation

See full
Market cap$1B+27.8%
Enterprise value$946.17M—
P/S348.8×—

Profitability

See full
Operating margin-6,129%—
Net margin-5,934%—

Returns & leverage

See full
Return on equity-8,434.8%—
Debt / equity0.1×—
Current ratio11.4×—